About
Intravenous Induction and Maintenance of Anesthesia
NEOPROL is the developer of a new formulation for anesthesia drugs. The companys NP-09 is an advanced preclinical development of an improved formulation and novel bioequivalent of propofol, with proven superiority over Diprivan. NEOPROLs formulation is based on an invention by Professor Nissim Garti.
Identity
| Name | NEOPROL |
|---|---|
| Slug | neoprol |
| Former names | Neoprol |
| Type / kind | startup |
| Crunchbase ID | neoprol |
| Source _id | agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAoMXPyoELDA |
Status
| Status | active |
|---|---|
| Last update | 2026-05-17 |
Location
| HQ country code | IL |
|---|---|
| HQ region/district | Jerusalem District |
| HQ city | Jerusalem |
| HQ address | Givat Ram, Jerusalem, Israel |
Web & social
| Website | https://www.integra-holdings.com/portfolio/neoprol |
|---|
Classifications
Primary sector Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
Materials & SubstancesNanomaterials
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticalsHealthcareProviders
Business models
B2B
Tags
nanotechnologypharmaceuticalslife-sciences
Funding
| Total raised | — |
|---|---|
| Current stage | Seed |
Raw source document
Show full JSON (0 KB)
{
"0": "s",
"1": "l",
"2": "i",
"3": "m",
"4": "p",
"5": "a",
"6": "g",
"7": "e",
"8": "s",
"9": "_",
"10": "i",
"11": "m",
"12": "p",
"13": "o",
"14": "r",
"15": "t"
}